<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20</volume><submitter>Krishnan DA</submitter><funding>Indian Council of Medical Research</funding><pubmed_abstract>The world is facing health and economic havoc due to the Corona Virus Disease-2019 (COVID-19) pandemic. Given the number of affected people and the mortality rate, the virus is undoubtedly a serious threat to humanity. By analogy with earlier reports about Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) - viruses, the novel Coronavirus' replication mechanism is likely well understood. The structure of an endoribonuclease (NSP15) of SARS-CoV-2 was reported recently. This enzyme is expected to play a crucial role in replication. In this work, attempts were made to identify inhibitors of this enzyme. To achieve the goal, high throughput &lt;i>in silico&lt;/i> screening and molecular docking procedures were performed. From an Enamine database of a billion</pubmed_abstract><journal>Informatics in medicine unlocked</journal><pagination>100392</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7351674</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15.</pubmed_title><pmcid>PMC7351674</pmcid><pubmed_authors>Sangeetha G</pubmed_authors><pubmed_authors>Vajravijayan S</pubmed_authors><pubmed_authors>Gunasekaran K</pubmed_authors><pubmed_authors>Krishnan DA</pubmed_authors><pubmed_authors>Nandhagopal N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15.</name><description>The world is facing health and economic havoc due to the Corona Virus Disease-2019 (COVID-19) pandemic. Given the number of affected people and the mortality rate, the virus is undoubtedly a serious threat to humanity. By analogy with earlier reports about Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) - viruses, the novel Coronavirus' replication mechanism is likely well understood. The structure of an endoribonuclease (NSP15) of SARS-CoV-2 was reported recently. This enzyme is expected to play a crucial role in replication. In this work, attempts were made to identify inhibitors of this enzyme. To achieve the goal, high throughput &lt;i>in silico&lt;/i> screening and molecular docking procedures were performed. From an Enamine database of a billion</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2026-04-07T22:27:50.916Z</modification><creation>2020-08-29T07:19:38Z</creation></dates><accession>S-EPMC7351674</accession><cross_references><pubmed>32835078</pubmed><doi>10.1016/j.imu.2020.100392</doi></cross_references></HashMap>